Pituitary

Article	Citations
Patient perceptions of pituitary incidentaloma diagnosis and follow-up: a Pituitary Society international patient survey	186
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas	64
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	59
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland	46
Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies	42
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	40
Clinicopathological features and outcomes of immature PIT-1 lineage tumors: A high-risk pituitary neuroendocrine tumor/pituitary adenoma subtype per WHO 2022	40
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study	36
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	35
Increased impulsivity and higher odds of compulsive shopping among cabergoline-treated patients with prolactinoma: a case-control study	27
Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life	25
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening	22
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients	22
The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly	21
Pituitary: hic manebimus optime	21
The efficacy of minimally invasive intraoperative ultrasound in endoscopic pituitary surgery	20
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery	19
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience	19
ACRODAT and SAGIT for the assessment of disease activity in acromegaly: a multicenter study of the Veneto region in Italy	19
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study	18
Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas	18
Psychological profiles of patients with acromegaly: personality traits, quality of life, and clinical correlates	18
Non-written guidelines in pituitary tumor surgery. The hidden curriculum	17
Genetic models of Cushing’s disease	16
Evaluating pituitary tumor management: aligning with pituitary tumor centers of excellence criteria	16

Pituitary metastases: a case series and scoping review	16
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome	15
Delayed diagnosis of ectopic ACTH-secreting tumors following transsphenoidal surgery for presumed MRI-negative Cushing’s disease: implications for long-term surveillance	15
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes	15
Authors‘ reply to the letter to the editor by Fedai et al.: “Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort”	15
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors	15
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants	15
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre	15
Consensus on acromegaly complications: an update	15
Diagnosis of growth hormone deficiency: searching for Consensus along life	15
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach	14
TSH-secreting pituitary adenomas and bone	14
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus)	14
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	14
Commentary: The updated European society of endocrinology clinical practice guideline for the management of aggressive pituitary tumors and pituitary carcinomas	14
IGF-1 is positively associated with BMI in patients with acromegaly	14
Diagnostic performance of desmopressin stimulation test in pediatric cushing’s disease	14
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	14
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	14
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)	13
Cushing’s disease and bone	13
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature	13
GH Stimulation testing is unnecessary in patients with hypothalamic–pituitary disease, preserved pituitary function, and IGF-I SDS ≥ 0	13
Response to letter to the editor “Hypopituitarism and COVID-19, what else?”	12
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation	12
Development and validation of clinical screening systems for Cushing disease in the United States	12
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly	12
From misclassified AIP variant to carney complex: a case report and retrospective evaluation of PRKAR1A in pituitary tumor predisposition	11
The impact of growth hormone (GH) on immunosenescence: exploring the role of B and T cells	11
Circadian rhythm proteins as potential biomarkers in pituitary adenomas: an immunohistochemical analysis	11
Outcomes in surgical management of microprolactinomas: an international multi-institutional series	11
Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study	11
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas	10
Copeptin after pituitary surgery: is it worth measuring?	10
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review	10
Long COVID and pituitary dysfunctions: a bidirectional relationship?	10
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade	10
Clinical, surgical, and endocrine outcome following treatment of posterior pituitary tumors: a retrospective cohort study	10
Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience	10
Determinants of remission and recurrence following transsphenoidal surgery for prolactinoma: a single-center experience	10
Pituitary surgery and COVID	10
Is diabetes with acromegaly for life?	10
Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly	10
Anemia in acromegaly: Prevalence, etiologies, and predictors from a large tertiary center cohort	10
Mortality in patients with dopamine agonist-treated hyperprolactinemia: a large matched-cohort study	9
The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohort	9
Impulse control disorders and their relationship with psychopathology in patients treated with cabergoline for hyperprolactinaemia	9
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort	9
Serum IGF-1 May be less reliable when assessing the GH-IGF-1 axis in the elderly	9
Gauze swabbing technique for safe dissection of pituitary tumors	9

Validation and modification of the PANOMEN 3 classification for predicting long-term recurrence/progression and quality of life in patients with pituitary adenomas: a multicentre retrospective cohort	9
SAGIT®, ACRODAT®, PANOMEN 3… time to implement tools for management of acromegaly..?	9
Nelson’s syndrome: reappraisal of an uncommon disease	9
Genetic evaluation of pediatric pituitary adenomas and USP8-related genotype-phenotype correlations in Cushing’s disease	8
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis	8
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon	8
Outcomes of stereotactic radiosurgery in nelson’s syndrome: a systematic review and Meta-Analysis	8
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings	8
Effect of antineoplastic drug therapies on carcinoma and aggressive pituitary tumors: a systematic review and meta-analysis	8
Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery – a prospective study	8
Higher surgical cure of pediatric gigantism with endoscopic endonasal surgery: case series and review of the literature	8
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma	8
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes	8
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese	8
Refractory nonfunctioning pituitary adenomas	8
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment	8
Correction: consensus on criteria for acromegaly diagnosis and remission	7
Cushing’s syndrome: Guidance on thromboprophylaxis at last	7
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence	7
Skeletal fragility in pituitary disease: how can we predict fracture risk?	7
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis	7
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans	7
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma	7
Clinician decision-making in non-functioning pituitary adenomas: an Australian and New Zealand interdisciplinary survey study	7
Surgical management in very elderly patients with pituitary adenoma: a multivariable assessment of the surveillance, epidemiology, and end results database	7
Pituitary stalk biopsy – A systematic review of the safety and efficacy of stalk lesion biopsy	7
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas	7
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas	7
Alert: misinformation that may hurt patients with both adrenal insufficiency and AVP deficiency	7
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours	7
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency	7
Recent progress in the understanding of psychological complications of acromegaly: toward a longitudinal clinical phenotype	7
How to manage intolerance to dopamine agonist in patients with prolactinoma	7
An update on, and genetics of refractory adenomas of childhood	7
The diagnosis of GH deficiency in adult β-thalassemic patients: are two different stimulation tests necessary to improve specificity?	7
A Retrospective cohort study of Knosp grade reporting of cavernous sinus invasion in pituitary macroadenomas	7
Etomidate in severe hypercortisolism: early cortisol kinetics and clinical outcomes in a real-world cohort	7
Giant prolactinomas, a detailed analysis of 196 adult cases	7
The effect of growth hormone replacement therapy on craniopharyngioma recurrence: a systematic review and meta-analysis	7
Prolactinoma-associated headache: Clinical and radiological correlates and long-term outcomes	6
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	6
Selective resection of the medial wall of the cavernous sinus in pituitary surgery: results of a prospective single center analysis	6
Pituitary Tumor Centers of Excellence (PTCOE) should now include neuro-oncologic input	6
Pregnancy and delivery after surgical remission in women with prolactinomas desiring pregnancy: Refining surgical indications	6
Postoperative weight gain following endoscopic endonasal surgery for craniopharyngiomas in children and adults: A retrospective cohort study	6
Sex differences in the clinical presentation, management and long-term outcomes of pituitary tumors in children and adolescents	6
Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants	6
Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study	6
Non-penetrant Xq26.3 duplication involving the invariant TAD border: clinical evidence for the VGLL1 region as the GPR101 pituitary enhancer of X-linked acrogigantism	6
Reported baseline variables in transsphenoidal surgery for pituitary adenoma over a 30 year period: a systematic review	6
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly	6
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan	6
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease	6
Correction: Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study	6
Old and new pituitary biomarkers: evidence for sex-specificity	6
Persistent barriers to growth hormone replacement therapy for adults	6
Critical views for safe surgical phase progression in endoscopic endonasal transsphenoidal pituitary adenoma resection: modified Delphi consensus	6
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19	6
Exercise ventilatory inefficiency may be a specific feature of patients with acromegaly	5
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center	5
Metastases to the pituitary gland: insights from the German pituitary tumor registry	5
Estimation of the biological variation of IGF-I in multimorbid geriatric patients and its clinical implications	5
Endoscopic endonasal transcavernous surgery for a contemporary series of 59 prolactinomas	5
Response to letter to the editor “proposed consideration for targeted immunotherapy in pituitary carcinomas and aggressive pituitary tumors”	5
Exploring the role of the tumor microenvironment in refractory pituitary tumor pathogenesis	5
Biochemical and metabolic tissue discrimination using a dual-modality Raman-fluorescence endonasal spectroscopy probe for pituitary adenoma surgery	5
Refractory Pit1 plurihormonal tumours and thyrotroph adenomas	5
Cushing’s syndrome and COVID-19	5
Craniopharyngioma – What’s next	5
Elevated risk of recurrence and retreatment for silent pituitary adenomas	5
The metabolic effects of glucocorticoid replacement therapy in patients with secondary adrenal insufficiency due to hypothalamic-pituitary diseases: results from a retrospective and longitudinal study	5
Impulse control disorders in patients with pituitary adenoma managed with or without dopamine agonists: a cross-sectional study from a UK centre	5
Correction to: Consensus and Controversies about Diagnosing GH deficiency - A Delphi Survey by the GH Research Society	5
Cushing’s disease: adrenal steroidogenesis inhibitors	5
The efficacy of a visiting surgical service versus that of a hospital-based surgical service in providing endoscopic endonasal surgery to remove nonfunctioning pituitary adenomas in rural communities	5
Impact of sex on mortality in patients with pituitary adenomas	5
Age and hematologic parameters can predict prolonged glucocorticoid replacement after remission of cushing disease and adrenal Cushing’s syndrome: A nationwide cohort study	5
Novel imaging techniques in refractory pituitary adenomas	5
Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency	5
Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center	5

Posterior pituitary tumors: an entity unto itself	5
Pituitary enlargement in patients with cerebrospinal fluid drainage due to ventricular shunt insertion: know the condition and do not mistake for adenoma	5
Patients with langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort	5
The role of stereotactic radiosurgery in the multidisciplinary management of pituitary metastases	5
Letter to the editor regarding “Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature”	5
Vitamin D in pituitary driven osteopathies	5
Refining surgical decision-making in patients with prolactinomas	5
GHR disruption in mature adult mice alters xenobiotic metabolism gene expression in the liver	5
Serum copeptin levels at day two after pituitary surgery and ratio to baseline predict postoperative central diabetes insipidus	5
High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors	4
Letter to the editor: Pituitary hyperplasia causing visual symptoms in a young woman planning pregnancy	4
Exploring sex-specific hematological changes and their impact on quality of life in patients with prolactinoma	4
Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma	4
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience	4
Precocious puberty, pandemic and beyond	4
Cardiovascular and metabolic outcomes of GH replacement therapy in adults with GH deficiency – gender gaps	4
Clinical characteristics, surgical and endocrinological outcomes of sellar and parasellar masses in pediatric patients: a single-center experience	4
Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists	4
Hormonal staining patterns and clinical outcomes in acromegaly: a 15-year single-center study	4
External validation of the PANOMEN-3 classification for predicting 1-year surgical remission in pituitary adenoma	4
Morphometric study of the pituitary gland and stalk with emphasis on lifestyle factors	4
Long-term cabergoline use does not predict degree of prolactinoma fibrosis nor significantly impact surgical outcomes	4
Changing the name of diabetes insipidus	4
Hypopituitarism and COVID-19	4
Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review	4
Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism	4
Disentangling secretory ambiguity and the limitations of classical thresholds in defining prolactinomas	4
Correction: Giant prolactinomas, a detailed analysis of 196 adult cases	4
Urinary incontinence as a novel and underrecognized clinical manifestation of prolactinoma in women	4
Sleep quality in patients with non-functioning pituitary adenoma: impact of replacement therapies with an emphasis on the time of hydrocortisone	4
Gender differences in surgical outcomes and predictors of long term endocrine and metabolic morbidity in adults with craniopharyngioma	4
Kidney function in acromegaly: evidence from a long-term observational study	4
Real-world insights in the use of temozolomide for aggressive pituitary tumours remind us what we still don’t know	4
Clinical and imaging findings for the evaluation of large Rathke’s cleft cysts and cystic craniopharyngiomas	4
Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing’s syndrome: a large population database study	4
Sheehan syndrome: a current approach to a dormant disease	4
Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?	4
Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	3
Current status of artificial intelligence technologies in pituitary adenoma surgery: a scoping review	3
A procedure in mice to obtain intact pituitary-infundibulum-hypothalamus preparations: a method to evaluate the reconstruction of hypothalamohypophyseal system	3
Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test	3
Differential diagnosis between Cushing’s syndrome and non-neoplastic hypercortisolism: are we getting there?	3
Management of hypopituitarism during pregnancy in patients with PROP1-related combined pituitary hormone deficiency: Review of the literature with a case report	3
Efficacy and safety of pasireotide treatment in acromegaly: A systematic review and single arm meta-analysis	3
Enhancing diagnostic tools for vasopressin deficiency: insights from a single-center cohort study	3
Letter to the editor: long-term endocrine trajectories and reoperation risk after surgery for Rathke’s cleft cysts: a single-center cohort study of 177 patients	3
Impact of nasal septal deviation on surgical outcomes in endoscopic transsphenoidal surgery: a population-based study	3
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study	3
Good response rates and predictors during the first year of cabergoline treatment in large invasive prolactinomas	3
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)	3
Post-operative surveillance for somatotroph, lactotroph and non-functional pituitary adenomas after curative resection: a systematic review	3
Epigenetic implications in the pathogenesis of corticotroph tumors	3
Repeat endoscopic endonasal transsphenoidal surgery for residual or recurrent Cushing’s disease: safety, feasibility, and success	3
FGFR1 variation in the divergent settings of congenital hypopituitarism and pituitary tumours	3
Reassuring long-term data on efficacy and safety of pegvisomant monotherapy in a large series of patients with acromegaly	3
“Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review”	3
Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification	3
Standardizing blood pressure phenotyping in acromegaly: A practical companion to Araujo-Castro et al.	3
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)	3
The Limited Role of Hypocortisolism in the Development of Delayed Postoperative Hyponatremia After Pituitary Surgery	3
Temporal and masseter muscle evaluation by MRI provides information on muscle mass and quality in acromegaly patients	3
Pituitary and COVID-19 vaccination: a systematic review	3
Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases	3
Impact of granulation pattern on surgical and long-term outcomes in Cushing’s disease: a comparative study of DGCT and SGCT	3
Predictive factors for post-therapeutic biochemical discordance in acromegaly: a monocentric analysis of 156 cases	3
Intranasal povidone-iodine concentration and olfactory recovery after endoscopic endonasal pituitary surgery	3
Authors’ reply to the Comment on Osteometabolic complications in patients with secreting pituitary adenomas: Is there an impact of gender?	3
Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society	3
To test or not to test: what we have learnt from 50 years of dynamic testing in acromegaly	3
Correlates of prolonged length of stay after endoscopic transsphenoidal surgery for pituitary adenomas: varying definitions and non-clinical factors	3
Two-stage surgery for cystic craniopharyngiomas: a purely endoscopic strategy and outcomes	3
Role of biological effective dose for prediction of endocrine remission in acromegaly patients treated with stereotactic radiosurgery	3
Anterior-posterior diameter is a key driver of resectability and complications for pituitary adenomas with suprasellar extension in endoscopic transsphenoidal surgery	3
Risk of new endocrinological deficits after intraoperative MRI-guided additional resection in endoscopic non-functioning pituitary adenoma surgery	2
Inflammation of adenohypophysis is commonly associated with headache in surgically managed Rathke’s cleft cysts	2
Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades	2
Evaluating the burden of endogenous Cushing’s syndrome using a web-based questionnaire and validated patient-reported outcome measures	2
Sex-Specific transcriptomic changes in adipose tissue following adult-onset disruption of growth hormone receptor	2
A core outcome set for pituitary surgery research: an international delphi consensus study	2
A fond farewell	2
Neuropathic foot ulcers in the tallest patients with acromegalic gigantism: a common and significant problem. Historical overview	2
Treatment of acromegaly-induced diabetes: an updated proposal	2
Acromegaly treatment and bone: a bidirectional relationship	2
Newer parameters of the octreotide test in patients with acromegaly	2
Outcomes of endoscopic endonasal surgery for pediatric craniopharyngioma with a focus on morphological preservation of the pituitary stalk and endocrine functions	2
Osteometabolic complications in patients with secreting pituitary adenomas: Is there an impact of gender?	2
Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2	2
Statistical clarification of neurological outcome estimates after pediatric suprasellar tumor surgery	2
Natural history of non-functioning pituitary neuroendocrine tumours: impact of baseline characteristics and gender-specific clinical presentations	2
Effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: an updated systematic review and meta-analysis	2
The feedback loop in pituitary surgery	2
Cytokines and chemokines modulate the growth of pituitary adenoma/neuroendocrine tumors: preliminary results of a monocenter prospective pilot study	2
Impulse control disorders in pituitary adenoma: What do we know and what we still don´t know in almost two decades?	2
SARS-CoV-2 infection and vaccination in patients with pituitary diseases: the experience of a Brazilian reference center	2
Postsurgical outcomes of nonfunctioning pituitary adenomas: a patient-level meta-analysis	2